Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tom Gallen

Managing Editor, Europe

Birmingham, UK
Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest From Tom Gallen

People On The Move: Appointments At AESGP, Alliance Pharma, FSE, Venture Life

A round-up of the latest appointments in Europe's consumer health industry: AESGP names Haleon's Workman as president; Alliance Pharma shareholders re-elect board; Food Supplements Europe re-elects Stada's Šímová as chair; and Venture Life announces departure of co-Founder and CCO Daly.

Europe Executive Changes

Sweden Drops Plans For Max Levels In Supplements After Commission Consultation

Sweden will not introduce proposed limits for vitamin D and iodine in dietary supplements after the European Commission warned it would create a disproportionate barrier to trade with other EU member states.

Dietary Supplements Regulation

Nestlé's Iron Deficiency Supplement Among Latest EU Novel Food Authorizations

A new source of iron manufactured by Nestlé is one of four novel foods to receive authorization by the European Commission for use in dietary supplements.

Europe Wellness

People On The Move: Appointments At ANEFP, CHPA, Norgine, InfectoPharm, DSM

A round-up of the latest appointments in Europe's and the US health and wellness industries: Spain's ANEFP elects Martín as president;  US CHPA appoints Parks as senior VP of regulatory and scientific affairs, Norgine hires HRA's Hilton to lead its consumer business; Infectopharm names Weleda's Ammendola as R&D head; and DSM-Firmenich makes management changes.

Executive Changes Leadership

UK Rejects Rx-To-OTC Switch Of Overactive Bladder Treatment

Maxwellia’s application to switch to non-prescription status in the UK Aquiette (oxybutynin hydrochloride) for the treatment of overactive bladder has been rejected by MHRA following a public consultation.

Prescription To OTC Switch United Kingdom

Bayer Blames Macroeconomic Pressures For Lower Volumes In Q1

Inflationary pressures and supply constraints led to volume declines at Bayer Consumer Health in Q1. However, price rises offset these headwinds helping the business to post a 4% rise in sales.

Sales & Earnings OTC Drugs
See All
UsernamePublicRestriction

Register